Executive Summary
Generated July 30, 2026
Robotics
1X Technologies
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
1
Chokepoint Score
1 other entity structurally depend on this one
Cooling
Activity
0 recorded changes in the last 90 days
Headquarters
Sunnyvale, California, USA (Norwegian origin)
Website
Employees
250 (2026, approximate)
Founded
2014
Listing
private
Overview
A humanoid robotics company developing Neo, a bipedal home robot priced at $20,000 (or $499/month subscription) targeting US households in 2026, having booked 10,000 pre-orders within five days of opening reservations. 1X commenced full-scale Neo production in April 2026 at its 58,000-square-foot NEO Factory in Hayward, California -- described as America's first vertically integrated high-volume humanoid robot factory -- and unveiled a tendon-driven, 22-25 degree-of-freedom robotic hand in June-July 2026 achieving near human-level dexterity.
Strategic Connections
- Autonomous Systems & Robotics: 1X Technologies develops Neo, a bipedal humanoid robot targeting the home/consumer market, part of the broader autonomous systems and robotics technology landscape.
- Figure AI: 1X Technologies competes with Figure AI and other humanoid robotics makers, though 1X is focused on the home/consumer market while Figure targets industrial deployment first.
Strategic Risks
- First-of-its-kind consumer home robot category carries significant unproven safety, privacy, and reliability risk
- Manufacturing scale-up from pilot to high-volume production is a common failure point for hardware startups
Future Outlook
- Scaling Neo deliveries against 10,000+ pre-order backlog through 2026
- Home robot category success could open a substantially larger consumer market beyond industrial humanoid deployment
Sources
2 sources, 61% average source confidence — full citations in the Full Analyst Report.
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Executive Summary — switch to the Full Analyst Report.